It is reported that dysregulation of LEPROT is associated with various bone inflammation diseases through key cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) (Rothzerg et al., 2020). This evidence concerns the gene TNF and bone inflammation disease.